ID Q53F80_HUMAN Unreviewed; 777 AA. AC Q53F80; DT 24-MAY-2005, integrated into UniProtKB/TrEMBL. DT 24-MAY-2005, sequence version 1. DT 31-JAN-2018, entry version 83. DE SubName: Full=BRCA1 associated RING domain 1 variant {ECO:0000313|EMBL:BAD97129.1}; DE Flags: Fragment; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD97129.1}; RN [1] {ECO:0000313|EMBL:BAD97129.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8; RA Maruyama K., Sugano S.; RT "Oligo-capping: a simple method to replace the cap structure of RT eukaryotic mRNAs with oligoribonucleotides."; RL Gene 138:171-174(1994). RN [2] {ECO:0000313|EMBL:BAD97129.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3; RA Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.; RT "Construction and characterization of a full length-enriched and a 5'- RT end-enriched cDNA library."; RL Gene 200:149-156(1997). RN [3] {ECO:0000313|EMBL:BAD97129.1} RP NUCLEOTIDE SEQUENCE. RA Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.; RL Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK223409; BAD97129.1; -; mRNA. DR UniGene; Hs.591642; -. DR UniGene; Hs.597413; -. DR ProteinModelPortal; Q53F80; -. DR PeptideAtlas; Q53F80; -. DR PRIDE; Q53F80; -. DR eggNOG; KOG0504; Eukaryota. DR eggNOG; KOG4362; Eukaryota. DR eggNOG; COG0666; LUCA. DR HOVERGEN; HBG050662; -. DR GO; GO:0031436; C:BRCA1-BARD1 complex; IEA:InterPro. DR GO; GO:0043065; P:positive regulation of apoptotic process; IEA:InterPro. DR GO; GO:0016567; P:protein ubiquitination; IEA:InterPro. DR CDD; cd00204; ANK; 1. DR CDD; cd00027; BRCT; 2. DR Gene3D; 1.25.40.20; -; 2. DR Gene3D; 3.30.40.10; -; 1. DR Gene3D; 3.40.50.10190; -; 2. DR InterPro; IPR002110; Ankyrin_rpt. DR InterPro; IPR020683; Ankyrin_rpt-contain_dom. DR InterPro; IPR036770; Ankyrin_rpt-contain_sf. DR InterPro; IPR033097; BARD1. DR InterPro; IPR001357; BRCT_dom. DR InterPro; IPR036420; BRCT_dom_sf. DR InterPro; IPR001841; Znf_RING. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR InterPro; IPR017907; Znf_RING_CS. DR PANTHER; PTHR24171:SF8; PTHR24171:SF8; 1. DR Pfam; PF12796; Ank_2; 1. DR Pfam; PF16589; BRCT_2; 1. DR PRINTS; PR01415; ANKYRIN. DR SMART; SM00248; ANK; 3. DR SMART; SM00292; BRCT; 2. DR SUPFAM; SSF48403; SSF48403; 1. DR SUPFAM; SSF52113; SSF52113; 2. DR PROSITE; PS50297; ANK_REP_REGION; 1. DR PROSITE; PS50088; ANK_REPEAT; 3. DR PROSITE; PS50172; BRCT; 2. DR PROSITE; PS00518; ZF_RING_1; 1. DR PROSITE; PS50089; ZF_RING_2; 1. PE 2: Evidence at transcript level; KW ANK repeat {ECO:0000256|PROSITE-ProRule:PRU00023}; KW Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175}; KW Zinc {ECO:0000256|PROSITE-ProRule:PRU00175}; KW Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}. FT DOMAIN 50 86 RING-type. {ECO:0000259|PROSITE:PS50089}. FT DOMAIN 427 525 ANK_REP_REGION. {ECO:0000259|PROSITE: FT PS50297}. FT REPEAT 427 459 ANK. {ECO:0000256|PROSITE-ProRule: FT PRU00023}. FT REPEAT 460 492 ANK. {ECO:0000256|PROSITE-ProRule: FT PRU00023}. FT REPEAT 493 525 ANK. {ECO:0000256|PROSITE-ProRule: FT PRU00023}. FT DOMAIN 570 653 BRCT. {ECO:0000259|PROSITE:PS50172}. FT DOMAIN 667 777 BRCT. {ECO:0000259|PROSITE:PS50172}. FT NON_TER 1 1 {ECO:0000313|EMBL:BAD97129.1}. SQ SEQUENCE 777 AA; 86496 MW; 8258990E33CB9341 CRC64; MPDNRQPRNR QPRIRSGNEP RSASAMEPDG RGAWAHSRAA LDRLEKLLRC SRCTNILREP VCLGGCEHIF CSNCVSDYIG TGCPVCYTPA WIQDLKINRQ LDSMIQLCSK LRNLLHDNEL SDLKEDKPRK GLFNDAGNKK NSIKMWFSPR SKKVRYVVSK ASVQTQPAIK KDASAQQDSY EFVSPSPPAD VSERAKKASA RSGKKQKKKT LAEINQKWNL EAEKEDGEFD SKEESKQKLV SFCSQPSVIS SPQINGEIDL LASGSLTESE CFGSLTEVSL PLAEQIESPD TKSRNEVVTP EKVCKNYLTS KKSLPLENNG KRGHHNRLSS PISKRCRTSI LSTSGDFVKQ TVPSENIPLP ECSSPPSCKR KVGGTSGSKN SNMSDEFISL SPGTPPSTLS SSSYRRVMSS PSAMKLLPNM AVKRNHRGET LLHIASIKGD IPSVEYLLQN GSDPNVKDHA GWTPLHEACN HGHLKVVELL LQHKALVNTT GYQNDSPLHD AAKNGHVDIV KLLLSYGASR NAVNIFGLRP VDYTDDESMK SLLLLPEKNE SSSASHCSVM NTGQRRDGPL VLIGSGLSSE QQKMLSGLAV ILKAKKYTEF DSTVTHVVVP GDAVQSTLKC MLGILNGCWI LKFEWVKACL RRKVCEQEEK YEIPEGPRRS RLNREQLLPK LFDGCYFYLW GTFKHHPKDN LIKLVTAGGG QILSRKPKPD SDVTQTINTV AYHARPDSDQ RFCTQYIIYE DLCNYHPERV RQGKVWKAPS SWFIDCVTSF ELLPLDS //